[go: up one dir, main page]

UA106224C2 - Crystalline insulin-conjugates - Google Patents

Crystalline insulin-conjugates

Info

Publication number
UA106224C2
UA106224C2 UAA201110420A UAA201110420A UA106224C2 UA 106224 C2 UA106224 C2 UA 106224C2 UA A201110420 A UAA201110420 A UA A201110420A UA A201110420 A UAA201110420 A UA A201110420A UA 106224 C2 UA106224 C2 UA 106224C2
Authority
UA
Ukraine
Prior art keywords
conjugates
crystalline insulin
methods
present disclosure
insulin
Prior art date
Application number
UAA201110420A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Тодд К. Зион
Томас М. Ланкастер
Original Assignee
Смартселлз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смартселлз, Инк. filed Critical Смартселлз, Инк.
Priority claimed from PCT/US2010/022277 external-priority patent/WO2010088300A1/en
Publication of UA106224C2 publication Critical patent/UA106224C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present disclosure provides crystalline insulin-conjugates. The present disclosure also provides formulations, methods of treatment, methods of administering, and methods of making that encompass these crystalline insulin-conjugates.
UAA201110420A 2009-01-28 2010-01-27 Crystalline insulin-conjugates UA106224C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14787809P 2009-01-28 2009-01-28
PCT/US2010/022277 WO2010088300A1 (en) 2009-01-28 2010-01-27 Crystalline insulin-conjugates

Publications (1)

Publication Number Publication Date
UA106224C2 true UA106224C2 (en) 2014-08-11

Family

ID=51229747

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201110419A UA104014C2 (en) 2009-01-28 2010-01-27 Conjugate for sustained release formulations of insulin
UAA201110420A UA106224C2 (en) 2009-01-28 2010-01-27 Crystalline insulin-conjugates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA201110419A UA104014C2 (en) 2009-01-28 2010-01-27 Conjugate for sustained release formulations of insulin

Country Status (2)

Country Link
HN (1) HN2011002077A (en)
UA (2) UA104014C2 (en)

Also Published As

Publication number Publication date
HN2011002077A (en) 2014-05-26
UA104014C2 (en) 2013-12-25

Similar Documents

Publication Publication Date Title
MX2011007930A (en) Crystalline insulin-conjugates.
WO2012048099A3 (en) Nanoparticle-loaded cells
MX2014011134A (en) Carbamate compounds and of making and using same.
MX343135B (en) Fumagillol type compounds and methods of making and using same.
TR201813877T4 (en) COMPOUNDS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY.
IN2015DN01156A (en)
MY181898A (en) Heterocyclic compounds and uses thereof
MX2011003473A (en) Oral care compositions.
MX355543B (en) Peptidomimetic macrocycles.
IN2012DN03883A (en)
MY172372A (en) Compositions and methods for lowering triglycerides
IN2012DN02081A (en)
EA201270619A1 (en) USE OF BETANEHOL FOR THE TREATMENT OF XEROSTOMY
MX2011011950A (en) Sublingual dexmedetomidine compositions and methods of use thereof.
MX341825B (en) Heteroaryl compounds and uses thereof.
MX2012001974A (en) Biaryl compounds and methods of use thereof.
MY158992A (en) Forms of rifaximin and uses thereof
IN2012DN02471A (en)
MX2021001169A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof.
MX2014004862A (en) Acrylic polymer formulations.
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
MX354988B (en) Antibody formulations and methods.
MX359769B (en) Methods of decellularizing bone.
MX2011011109A (en) Oral formulations of bendamustine.